David McLean > McGuireWoods LLP > Dallas, United States > Lawyer Profile

McGuireWoods LLP
2000 MCKINNEY AVENUE
SUITE 1400
DALLAS, TX 75201
United States

Career

David McLean advises private investment funds and sponsors in their equity and debt investing activities. His deep experience up and down the capital stack allows him to bring a broad range of expertise to his clients, together with the deep market insight, knowledge and relationships that accompany that experience.

David regularly counsels clients on all types of investing activities, from venture capital, minority equity, growth equity and control buyouts, to venture lending, mezzanine finance and senior lending. He has over 19 years of practice, with a particular focus on junior capital and the investment funds that focus in this sector.

David and his team bring a partner approach to their clients, with an emphasis on providing value-added services that go beyond the mere execution of transactions.

Lawyer Rankings

United States > M&A/corporate and commercial > Private equity buyouts

Maintaining its strength in the middle-market, McGuireWoods LLP has a prolific private equity offering that enjoys productive relationships with a wide range of funds. The firm specializes in healthcare private equity work, advising on a significant share of deals for both healthcare-focused funds and their portfolio companies. Other areas of strength include technology, energy, and industrials, alongside a growing focus on the ‘fundless’ or independent sponsor space, in which the firm has set up a bespoke platform. Chicago-based Geoffrey Cockrell co-heads the team, working regularly with a broad base of long-term sponsor clients, alongside Pittsburgh’s Thomas Zahn , who advises funds, sponsors, and other investors on deals in a variety of industries and jurisdictions, focusing on cross-border buyouts and investments. In Dallas, David McLean has expertise across debt and equity investments, particularly for junior capital funds, while Jon Finger leads the way on the firm’s independent sponsor advice, while maintaining his active dealmaking practice.